Ligand Pharmaceuticals | LGND - Koszty Sprzedaży





Koszty Sprzedaży Zmiana Data
Agenus USD 642K 399K 2025-09
Amgen USD 1.87B 271M 2026-06
Anika Therapeutics USD 11.44M 797K 2025-12
Baxter International USD 1.93B 118M 2026-06
Bristol-Myers Squibb USD 7.89B 4.03B 2026-06
Eli Lilly USD 3.27B 309M 2026-06
Enviri Corporation USD 472M 17.65M 2025-12
Gilead Sciences USD 1000M 445M 2026-06
GlaxoSmithKline GBP 2.07B 192M 2026-06
Glaxosmithkline GBP 1.88B 1.6B 2026-03
Heron Therapeutics USD 11.12M 795K 2025-12
Insmed USD 69.29M 19.79M 2026-06
Intrexon USD 1.01M 344K 2024-06
Ionis Pharmaceuticals USD 2.74M 261K 2026-06
Karyopharm Therapeutics USD 1.34M 139K 2026-03
Ligand Pharmaceuticals USD 11.31M 59K 2026-06
MacroGenics USD 9.53M 585K 2026-03
Merck USD 3.14B 200M 2026-06
Pacira USD 58.49M 7.75M 2026-06
Pfizer USD 4.09B 498M 2026-06
Rigel Pharmaceuticals USD 8.03M 5.22M 2024-09
Sangamo BioSciences 2.42M 1.11M 2024-06
Veracyte USD 42.19M 3.7M 2026-06